INACTIVATION: HIV VACCINE RESEARCH AND DESIGN - R01 GRANTS

Release Date:  October 4, 1999

PA NUMBER: PA-98-089

National Institute of Allergy and Infectious Diseases

The National Institute of Allergy and Infectious Diseases 
(NIAID) is inactivating program announcement PA 98-089, HIV 
VACCINE RESEARCH AND DESIGN � RESEARCH PROJECT GRANTS, 
which appeared in the NIH Guide, July 9, 1998.  

The areas of investigator-initiated vaccine research this 
PA targeted have received numerous responses that have been 
well-received in the NIH peer review system.  Accordingly 
NIAID will no longer give special consideration for funding 
to applications in response to this PA received after 
January 2, 2000. NIAID will, however, continue to give 
special consideration for funding to applications in 
response to PAR 98-090, HIV VACCINE RESEARCH AND DESIGN � 
PROGRAM PROJECT GRANTS, which also appeared in the NIH 
Guide, July 9, 1998.  NIAID supports highly scientifically 
meritorious applications in all areas of research within 
its mission.

PA inactivation simply means that special consideration for 
funding beyond normal paylines will NO LONGER be given to 
applications on the research topics identified in the 
inactivated PAs.  However, such applications will be 
accepted, reviewed, and considered for funding according 
the usual procedures.  At any time, potential applicants 
can obtain a current listing of active NIAID PAs on the 
NIAID WWW site at URL: 
http://www.niaid.nih.gov/ncn/budget/pas.htm

INQUIRIES

For questions or further information, contact:

Steve Bende, Ph.D.
NIH, NIAID, VPRP Room 4107
6700-B Rockledge Drive MSC 7628
Bethesda, MD 20892-7628
Telephone: (301) 435-3756
Fax: (301) 402-3684
Email: [email protected]

Return to Volume Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)